Seven Fleet Capital Management LP Invests $783,000 in Celcuity, Inc. $CELC

Seven Fleet Capital Management LP acquired a new stake in Celcuity, Inc. (NASDAQ:CELC) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,849 shares of the company’s stock, valued at approximately $783,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its stake in Celcuity by 1,329.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 343 shares of the company’s stock worth $34,000 after purchasing an additional 319 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in Celcuity during the fourth quarter worth approximately $42,000. Ogorek Anthony Joseph NY ADV raised its holdings in Celcuity by 19.7% during the fourth quarter. Ogorek Anthony Joseph NY ADV now owns 662 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares in the last quarter. US Bancorp DE lifted its position in shares of Celcuity by 25.4% during the 3rd quarter. US Bancorp DE now owns 706 shares of the company’s stock worth $35,000 after buying an additional 143 shares during the last quarter. Finally, NBC Securities Inc. purchased a new stake in shares of Celcuity during the 4th quarter worth approximately $99,000. Institutional investors and hedge funds own 63.33% of the company’s stock.

Celcuity Stock Down 0.3%

CELC stock opened at $87.76 on Friday. The company has a market cap of $4.28 billion, a price-to-earnings ratio of -22.50 and a beta of 0.10. The company has a fifty day moving average price of $117.74 and a 200 day moving average price of $110.95. The company has a debt-to-equity ratio of 6.04, a current ratio of 12.31 and a quick ratio of 12.31. Celcuity, Inc. has a 12 month low of $11.27 and a 12 month high of $151.02.

Celcuity (NASDAQ:CELC) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.97) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.07) by $0.10. Sell-side analysts expect that Celcuity, Inc. will post -3.69 earnings per share for the current year.

Insider Transactions at Celcuity

In related news, Director Richard E. Buller sold 9,000 shares of the firm’s stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the transaction, the director owned 6,760 shares of the company’s stock, valued at $949,509.60. This trade represents a 57.11% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director David Dalvey sold 25,000 shares of the business’s stock in a transaction dated Monday, May 4th. The shares were sold at an average price of $140.68, for a total value of $3,517,000.00. Following the completion of the transaction, the director owned 65,000 shares in the company, valued at $9,144,200. This trade represents a 27.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 37,000 shares of company stock worth $5,111,950. Corporate insiders own 13.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CELC. Weiss Ratings raised shares of Celcuity from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. Citigroup restated a “market outperform” rating on shares of Celcuity in a research note on Thursday, May 28th. HC Wainwright dropped their price objective on Celcuity from $185.00 to $145.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Leerink Partners set a $155.00 target price on Celcuity in a research report on Tuesday, June 2nd. Finally, Macquarie Infrastructure set a $160.00 target price on Celcuity in a report on Thursday, May 28th. Eleven analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $152.09.

Celcuity Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.